Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France
<p>Abstract</p> <p>Background</p> <p>Most European health care systems are suffering from the impact of demographic change. In short, aging of society is leading to higher costs of treatment per capita, while reproduction rates below 2.1 children per woman lead to a red...
Main Authors: | Boecking Wolfgang, Klamar Anna, Kitzmann Florian, Kirch Wilhelm |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2458/12/894 |
Similar Items
-
Demographics of France - Historical Analysis and Contemporary State
by: Dragan Petrović
Published: (2013-12-01) -
Efficiency of the medium-term planning of federal expenditures in Germany: main structural changes
by: Maria Gracheva,
Published: (2019-02-01) -
DETERMINATION OF THE LEVEL OF EXPENSES FOR MANAGEMENT OF THE ENTERPRISE
by: A. A. Svirina
Published: (2016-12-01) -
Radical Islamism in Germany and France – trends and challenges
by: Alexander Kamkin
Published: (2018-12-01) -
Pricing and reimbursement of innovative pharmaceuticals in France and the new healthcare reform
by: Alexander Natz, et al.
Published: (2012-06-01)